Recent Coverage


September 25, 2014

Seeking Alpha Article – RepliCel Offers Significant Upside
To view the article as it appears on Seeking Alpha, click here. Summary RepliCel is a rare blend of upside potential and risk mitigation. The... Read full article

September 9, 2014

September 9th, 2014- Featured in the Financial Post: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body
To read the full report click here: RepliCel’s Cutting-Edge Advancements The following has been published in the Financial Post: There is enormous interest in... Read full article

September 9, 2014

September 9th, 2014- RepliCel marches ahead with cell therapy trials
New in BioWorld, the latest in RepliCel’s cell therapy trials and what they could mean for improving Achilles tendinosis, aging and sun-damaged skin. Read full article

August 7, 2014

August 7, 2014 – Mark Landy from Summer Street Research Partners Comments on RepliCel in August’s issues of The Life Sciences Report
To read the full report click here: Mark Landy on New Growth Ideas for Biotech Investors The following is an excerpt from The Life... Read full article

July 15, 2014

BioWatch News – RepliCel as a Featured Company in June’s Issue Exploring Alopecia and its Industry
Cell therapies for curing alopecia are early in their clinical development. These must still show evidence of durable and robust efficacy. Nevertheless, it bears... Read full article

July 10, 2014

July 10, 2014 – Alan Leong from BioWatch News Comments on RepliCel in July’s Issues of The Life Sciences Report
For the full article click here: Alan Leong Interview on Niche Biotech Prospects Read below for an excerpt from Street Wise Reports  on Alan... Read full article

June 19, 2014

Yahoo Sports Article – RepliCel interviewed on Cristiano Ronaldo’s obscure injury could open door for U.S.
By Martin Rogers June 8, 2014 11:14 PM Yahoo Sports SAO PAULO – To a medical student, tendinosis is a non-inflammatory condition involving a... Read full article

May 27, 2014

Cell Therapy Group Interview with CEO, David Hall
Despite us both living in the Vancouver area and both being involved in cell therapy, I didn’t meet David Hall until we were both... Read full article

February 26, 2014

RepliCel Life Sciences Inc. (TSXV: RP) Seeks to Heal with Patients Own Cells
FINANCIAL POST ARTICLE PUBLISHED ON FEBRUARY 25, 2014 Imagine using healthy cells from your body to heal areas in which other cells are damaged... Read full article

January 13, 2014

Vancouver hair-loss biotech wins Japanese patent
BUSINESS IN VANCOUVER ARTICLE PUBLISHED ON JANUARY 13, 2014 Vancouver-based RepliCel Life Sciences Inc., a clinical stage biopharmaceutical company, has been granted a patent... Read full article